Abbott Halts Sales Of Weight-loss Drug

Abbott Laboratories said it is pulling prescription weight-loss drug Meridia from the U.S., Canadian and Australian markets, following a study suggesting it increased risk of serious cardiovascular events in patients with heart problems.

BING NEWS:
  • Eli Lilly weight loss drug shows promise treating sleep apnea, long linked to obesity
    The results, while unpublished, are the latest in a string of hopeful signs for weight loss drugs to treat a variety of conditions.
    04/17/2024 - 5:46 am | View Link
  • Eli Lilly’s weight-loss drug succeeds in trials with sleep apnea patients
    Eli Lilly's weight-loss drug helped cut the frequency of irregular breathing in patients with obstructive sleep apnea by as much as 63% on average across two late-stage trials, the company said on ...
    04/17/2024 - 12:35 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News